International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
PDX1 in human cancers: Molecular mechanisms, dual roles and clinical implications (Review)
Pancreatic and duodenal homeobox gene 1 (PDX1) is a critical transcription factor involved in pancreatic development and the functionality of mature β‑cells. PDX1 regulates key genes, including insulin and GLUT2, through its DNA‑binding homologous structural domain. In tumors, PDX1 exhibits complex, context‑dependent functions. In pancreatic ductal adenocarcinoma, it transitions from inhibiting follicular cell transformation to promoting tumor proliferation and preventing apoptosis, ultimately inhibiting epithelial‑mesenchymal transition during metastasis. In gastric cancer, PDX1 acts as a tumor suppressor gene, while in esophageal, colorectal, and prostate cancers, it plays a pro‑oncogenic role. Given the dual role of PDX1 in tumorigenesis, its aberrant expression offers potential applications in tumor diagnosis, treatment, and prognosis. The present review explored the structure, function, and mechanisms of PDX1 in tumors, as well as its clinical translational potential, aiming to provide insights for further basic research and pave the way for clinical drug development.